Loading search results
MyRIAD
Sponsor study identifier
Secondary identifiers
observational
105
1 country
10
Study Start
May 1, 2015
Actual (reported)Primary Completion
July 31, 2020
Actual (reported)Study Completion
December 31, 2020
Actual (reported)The objective of this study is to determine the mechanisms of stroke in patients with Intracranial Atherosclerotic Disease (IAD) by specifically evaluating limitations of antegrade flow through the stenotic artery, distal tissue perfusion to the affected territory, and artery-to-artery embolism. The hypothesis is that non-invasive imaging biomarkers that stratify stroke risk and distinguish mechanisms of IAD. This prospective multicenter study will enroll 175 patients with recently symptomatic high-grade IAD. Patients will be studied within 21 days of the index event (allowing appropriate time to arrange for diverse imaging modalities), with the following advanced neuroimaging techniques to elucidate mechanisms of recurrent ischemia:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2020
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
April 18, 2014
Actual (reported)April 23, 2014
Actual (reported)May 1, 2015
Actual (reported)July 31, 2020
Actual (reported)December 31, 2020
Actual (reported)Recurrent stroke in the territory of the symptomatic artery
Time to ischemic stroke in the territory of the symptomatic artery. Stroke is ascertained by the site neurologist and defined as new or worsening symptoms lasting \>24 hours and associated with imaging evidence of ischemia on CT or MRI in the distribution of the stenotic artery.
1 year
TIA in the territory of the stenotic artery
1 year
Silent infarcts in the distribution of the stenotic artery
6-8 weeks
Risk of combined microembolic signals and impaired vasomotor reactivity.
1 year
Risk of combined poor ante grade flow and poor distal tissue perfusion.
1 year
Stroke/TIA due to high grade IAD ≤21 days from symptom onset.
Eligible patients will have a recent stroke or TIA due to intracranial Atherosclerotic Disease (IAD) of 50-99% .
University of Alabama at Birmingham
Birmingham, Alabama, 35294, United States
UCLA
Los Angeles, California, 90095, United States
University of Florida
Gainesville, Florida, 32611, United States
Mayo Clinic Jacksonville
Jacksonville, Florida, 32224, United States
University of Miami
Miami, Florida, 33136, United States
Northwestern University Department of Radiology
Chicago, Illinois, 60611, United States
Rush University Medical Center
Chicago, Illinois, 60612, United States
Prabhakaran S, Liebeskind DS, Cotsonis G, Nizam A, Feldmann E, Sangha RS, Campo-Bustillo I, Romano JG; MYRIAD Investigators. Predictors of Early Infarct Recurrence in Patients With Symptomatic Intracranial Atherosclerotic Disease. Stroke. 2021 Jun;52(6):1961-1966. doi: 10.1161/STROKEAHA.120.032676. Epub 2021 Apr 19.
Romano JG, Prabhakaran S, Nizam A, Feldmann E, Sangha R, Cotsonis G, Campo-Bustillo I, Koch S, Rundek T, Chimowitz MI, Liebeskind DS; MyRIAD Investigators. Infarct Recurrence in Intracranial Atherosclerosis: Results from the MyRIAD Study. J Stroke Cerebrovasc Dis. 2021 Feb;30(2):105504. doi: 10.1016/j.jstrokecerebrovasdis.2020.105504. Epub 2020 Dec 1.
Jose G Romano, MD
University of Miami
Shyam Prabhakaran, MD
University of Chicago
David S Liebeskind, MD
University of California, Los Angeles
105 participants (actual enrollment reported by the registry).
First Submitted
April 18, 2014
First Posted
April 23, 2014
Study Start
May 1, 2015
Actual (reported)Contact the study team to confirm eligibility.
Columbia University Medical Center
New York, New York, 10032, United States
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
The University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
Primary Completion
July 31, 2020
Actual (reported)Study Completion
December 31, 2020
Actual (reported)Last Updated
May 28, 2021
Record last verified: 2021-05
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: